Barnett & Company’s Idexx Laboratories IDXX Stock Holding History

Barnett & Company’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-166	Closed	-$36K	–	350
2018 Q2	$36K	Hold	166	–	–	0.02%	200
2018 Q1	$32K	Hold	166	–	–	0.02%	205
2017 Q4	$26K	Hold	166	–	–	0.01%	223
2017 Q3	$26K	Hold	166	–	–	0.01%	222
2017 Q2	$27K	Hold	166	–	–	0.01%	241
2017 Q1	$26K	Hold	166	–	–	0.01%	220
2016 Q4	$19K	Hold	166	–	–	0.01%	274
2016 Q3	$19K	Hold	166	–	–	0.01%	282
2016 Q2	$15K	Hold	166	–	–	0.01%	290
2016 Q1	$13K	Buy	+166	New	+$12K	0.01%	315

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Barnett & Company's IDXX Position: Q3 2018 in Review

Barnett & Company sold out of Idexx Laboratories (IDXX) in Q3 2018, closing a stake of 166 shares — an estimated $36K sold.

Barnett & Company first reported a position in IDXX in Q1 2016 and held it in 10 quarters. The position peaked at $36K in Q2 2018. 698 funds tracked by Wall St. Rank hold IDXX as of Q3 2018.

Barnett & Company reported no remaining Idexx Laboratories position as of Q3 2018 after selling out during the quarter.
Barnett & Company sold 166 Idexx Laboratories shares in Q3 2018, an estimated $36K.
Barnett & Company first reported a position in Idexx Laboratories in Q1 2016 and held it in 10 quarters.
Barnett & Company's Idexx Laboratories position peaked at $36K in Q2 2018.
698 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2018.

Based on Barnett & Company's 13F filing for Q3 2018, filed 2 Nov 2018.